Announcements Trials

Browse Landscape

Sponsor

Conditions

Interventions

Magnetic Resonance Spectroscopy 8 Specimen Handling 5 Nivolumab 5 selpercatinib 4 Iodine-124 4 Biopsy 4 pembrolizumab 3 binimetinib 3 Iodine-131 3 Cetuximab 3 ulixertinib 2 trametinib 2 omipalisib 2 lenvatinib 2 larotrectinib 2 durvalumab 2 defactinib 2 dabrafenib 2 Surveys and Questionnaires 2 Sunitinib 2 Radiosurgery 2 Ipilimumab 2 Immunoglobulin G 2 Gemcitabine 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 tremelimumab 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Neoplasms × naporafenib × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡